Navigation Links
Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Date:2/12/2008

(146)

Special and

acquisition

related charges 84 - (84) - -

Equity income (2,049) - - - (2,049)

(Loss)/income

before income taxes (1,215) 4,080 (453) 197 2,609

Income tax expense 258 89 2 1 350

Net (loss)/income

before cumulative

effect of a change

in accounting

principle $(1,473) $3,991 $(455) $196 $2,259

Cumulative effect

of a change in

accounting principle,

net of tax - - - - -

Net (loss)/income $(1,473) $3,991 $(455) $196 $2,259

Preferred stock

dividends 118 - - - 118

Net (loss)/income

available to

common

shareholders $(1,591) $3,991 $(455) $196 $2,141

Diluted (loss)/

earnings per

common share:

(Loss)/earnings

available to

common shareholders

before cumulative

effect of a change

in accounting

principle $ (1.04) $1.37

Cumulative effect

of a change in

accounting principle,

net of tax - -

Diluted (loss)/

earnings per

common share $ (1.04) $1.37

Average common

shares outstanding

-diluted 1,536 1,607

SCHERING-PLOUGH CORPORATION

Reconciliation from Reported Net Income Available to Common Shareholders and Reported Diluted Earnings Per Common Share to As Reconciled Amounts for Net Income

Available to Common Shareholders and Diluted Earnings per Commo
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
2. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
3. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
4. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
5. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
6. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
9. Schering-Plough Completes Acquisition of Organon BioSciences
10. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
11. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., COPENHAGEN, Nov. 19 Danish Pri...n cellulosic ethanol plant in Kalundborg, Denmark,... the world,s first and largest 2nd generation etha...erase enzymes are used in the plant,s innovative p...ivision of Danisco, was the first to market with c...
(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/...vator in biotechnology for diabetes therapy, and a...ervices to food, supplement, biotechnology and pha... of Tuesday,s Annual Meeting of Shareholders. ,...ated (Nasdaq: SPEX ) elected the following member...
(Date:11/19/2009)... World,s Top Gene Synthesis Com...m (IGSC) to Coordinate Best Practices in Risk Redu...t of Worldwide Gene Synthesis Capacity , ...of the world’s leading gene synthesis compan... a common screening protocol to promote biosecurit...
(Date:11/18/2009)...Security personnel need to be able to find explosi...with them. To aid such searches, the National Inst...port from the Department of Homeland Security, has...ndard Reference Material (SRM) 2905, Trace Particu...ory assay methods, the SRM will be helpful in cali...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4New NIST trace explosives standard slated for homeland security duty 2
...Epicurian Coli XL1-Red cells allow isolation of ...T. Bornscheuer Markus M.,Enzelberger ,Insti...ttgart, Stuttgart,Germany , Josef Altenbuchne... of Stuttgart, Stuttgart,Germany , Hartmut H....ity of Hannover, Hannover, Germany , Mutants of ...
...Easy RNA purification with integrated DNA-removal ...ne , The StrataPrep total RNA miniprep kit eff... 5 to 10 7 cultured,cells or 10 to 40 mg of ...,Additionally, multiple samples can be processed...chnique. The RNA isolation is performed within mic...
... , ,,, ,Determine retrovira...,virtually any target cell line , Brenda Rog...gene , We describe three new ViraPort retroviral...cZ , ,and pFB-Luc ,which can ...ene expression in,virtually any target cell line...
Other Biology Technology:Using XL1-Red Mutator Strain to Generate Esterase Variants 2Using XL1-Red Mutator Strain to Generate Esterase Variants 3Using XL1-Red Mutator Strain to Generate Esterase Variants 4Using XL1-Red Mutator Strain to Generate Esterase Variants 5Simple Isolation of RNA from Tissue and Cultured Cells 2Simple Isolation of RNA from Tissue and Cultured Cells 3Simple Isolation of RNA from Tissue and Cultured Cells 4Simple Isolation of RNA from Tissue and Cultured Cells 5Simple Isolation of RNA from Tissue and Cultured Cells 6Simple Isolation of RNA from Tissue and Cultured Cells 7Simple Isolation of RNA from Tissue and Cultured Cells 8Versatile Reporter Vectors for Monitoring Viral Transduction 2Versatile Reporter Vectors for Monitoring Viral Transduction 3Versatile Reporter Vectors for Monitoring Viral Transduction 4Versatile Reporter Vectors for Monitoring Viral Transduction 5Versatile Reporter Vectors for Monitoring Viral Transduction 6
(Date:11/20/2009)... Using highly precise measurements of plasma lipop...ic resonance spectroscopy (NMR), researchers led b...nd Harvard Medical School in Boston, MA, the Frami... consortium in Stockholm, Sweden and Oxford, Engla...he whole genome among 17,296 women of European anc...
(Date:11/20/2009)... North Grafton, Mass., November 19, 2009 The esti... industry may be at risk of developing respiratory...according to a questionnaire study undertaken earl...,s Cummings School of Veterinary Medicine. , The...barn workersfound that 50 percent of individuals w...
(Date:11/20/2009)... Surplus biomass from the production of flax shive...w-flowered plant related to those which engulf fie...This has been suggested by two studies carried out... the journal Renewable and Sustainable Energy Rev...mental point of view, the production of bioethanol...
Breaking Biology News(10 mins):Genetic analysis helps dissect molecular basis of cardiovascular disease 2Barn personnel experience higher-than-average rates of respiratory symptoms 2Flax and yellow flowers can produce bioethanol 2New Study Results Analyzed the Use of KAPIDEX 28TM 29 28dexlansoprazole 29 for Nighttime Heartburn in Adults with Non Erosive GERD 5694 1New Study Results Analyzed the Use of KAPIDEX 28TM 29 28dexlansoprazole 29 for Nighttime Heartburn in Adults with Non Erosive GERD 5694 2New Study Results Analyzed the Use of KAPIDEX 28TM 29 28dexlansoprazole 29 for Nighttime Heartburn in Adults with Non Erosive GERD 5694 3M D Anderson redefines screening guidelines for breast cervical and colorectal cancers 60091 1M D Anderson redefines screening guidelines for breast cervical and colorectal cancers 60091 2M D Anderson redefines screening guidelines for breast cervical and colorectal cancers 60091 3M D Anderson redefines screening guidelines for breast cervical and colorectal cancers 60091 4Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 1Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 2Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 3
... NY) ─ For the third time in 14 months, the ...nstein College of Medicine of Yeshiva University f...aling $12.7 million, will help create technologies...d liver disease, as well as obesity and hepatitis....r restoring federal funding for stem cell research...
...rsity of Miami,s Rosenstiel School of Marine and A...ected Rosalind E.M. Rickaby, Ph.D., as recipient o... in Biogeochemistry and a Tutorial Fellow of Wolfs...th Sciences at the University of Oxford. Her curre...oplankton and dissolved carbon dioxide in the ocea...
... the toxoplasmosis parasite may trigger the develo.... , The team from the University of Leeds, Facult...arasite may play a role in the development of thes...e - the chemical that relays messages in the brain...haviour. , Toxoplasmosis, which is transmitted vi...
Other Biology News:Empire State Stem Cell Board awards $12.7 million to Albert Einstein College of Medicine 2Empire State Stem Cell Board awards $12.7 million to Albert Einstein College of Medicine 3Oxford's Dr. Rosalind Rickaby receives 2009 Rosenstiel Award 2Oxford's Dr. Rosalind Rickaby receives 2009 Rosenstiel Award 3Research supports toxoplasmosis link to schizophrenia 2
...m for fluorescent light due to small pixel size. E... level light in animals or plants in tumor researc...ircadian rhythm, gels and Western blots. NightOWL ...de the light-tight cabinet. This function allows c...
Mouse Anti-Human IFNA13 Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-SF3B2 Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-Human UGT2B10 Monoclonal Antibody, Unconjugated, Clone 2D9 from Novus Biologicals
Biology Products: